FCGRT and autoimmune disease: FcRn blockade offers a novel, targeted, and non-immunosuppressive approach to managing IgG-driven autoimmune diseases by lowering pathogenic antibody levels, improving symptoms, and potentially reducing reliance on corticosteroids and other broad immunosuppressants.